$248 million in cash from Sanofi, and the same amount in a capital contribution by Verily (not in cash) have breathed life to a new company — Onduo — where the two equal partners will wage battle with a formidable enemy: diabetes.
{iframe}http://medcitynews.com/2016/09/verily-sanofi-diabetes-onduo-behavior-change/?utm_source=hs_email&utm_medium=email&utm_content=34206774&_hsenc=p2ANqtz–QuCLTFycjYTfcxizxQ98TlUcppJufv8m2FLFWqKNlkKh9uO9nIaG05NpI-wAnlh1Q2wSaw9Z9YzabX3Bia93bayYlwA&_hsmi=34206774{/iframe}